Friday, 16 October 2026European Markets

ATOS Stock Plummets Over 21% On Tuesday: What's The Reason?

Loading stream...

(vianews) - according to recent data, atos shares (cac 40: ato.pa) experienced an unprecedented 21.67% drop at 14:50 est on tuesday - this drop followed two consecutive sessions of losses and yet cac 40 index is showing an uptick of 0.27% at eur8,170.13, seemingly defying downward trends seen earlier. although recent volatility could still occur within this market environment, bullish trends seem more prevalent now.

about atos

atos se is a leading global provider of digital transformation solutions, providing services such as advanced computing, analytics, ai and automation; cloud solutions; customer journey analytics; digital consulting services; workplace solutions for modern applications and platforms; edge computing as well as cybersecurity and infrastructure services for industries including financial services, healthcare, manufacturing, public sector resources telecom media entertainment. established in 1982 and based out of bezons france.

technical analysis

volume atos recently experienced an extraordinary trading volume increase of 185.19% above its average volume of 2,492,940 - this represents significant interest among investors for this stock. atos has experienced various levels of volatility over the last week, month, and quarter. last week's intraday variation average was positive by 0.82% while in july it recorded negative variance by 0.19%; during q3, atos saw its intraday variation average turn positive with an impressive increase to 5.0% (+5% last month and 5.0%+1% last quarter). atos saw the highest amplitude average volatility at 4.99% per week (4.999% +4.54% last month +5.07% last quarter).

equity analysis

earnings per share (eps) is a financial metric used to measure how much of a company's profit is allocated per outstanding share of stock. according to this text, atos currently boasts a trailing 12-month eps of eur-10.01. atos' annual loss per share stands at eur10.01, suggesting it has experienced financial difficulties over the last 12 months and may no longer be profitable. such information can assist investors in assessing atos' financial performance as well as its future growth potential and profitability.

more news about atos (ato.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com